These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1757058)

  • 1. [A galenic diclofenac more wisely packaged?. Interview by Dr. T. U. Keil].
    Brune K
    Fortschr Med; 1991 Sep; 109(28):91-2, 95. PubMed ID: 1757058
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advantages and problems of depot preparations].
    Abshagen U; Demmer F
    Med Klin; 1981 Aug; 76(18):484-90. PubMed ID: 7278789
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic equivalence of diclofenac sustained-released 75 mg tablets and diclofenac enteric-coated 50 mg tablets in the treatment of painful osteoarthritis.
    Le Loët X; Dreiser RL; Le Gros V; Febvre N
    Int J Clin Pract; 1997 Sep; 51(6):389-93. PubMed ID: 9489070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.
    Cannon GW; Caldwell JR; Holt P; McLean B; Seidenberg B; Bolognese J; Ehrich E; Mukhopadhyay S; Daniels B
    Arthritis Rheum; 2000 May; 43(5):978-87. PubMed ID: 10817549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of slow-release sodium diclofenac in patients with rheumatoid arthritis].
    Zorzin L; Maira MG; Giobbio A; Capone M
    Clin Ter; 1985 Jul; 114(2):105-10. PubMed ID: 4053529
    [No Abstract]   [Full Text] [Related]  

  • 6. [Which drug interactions the general practitioner should know].
    Haffner S; Thürmann PA
    Med Klin (Munich); 2004 Mar; 99(3):137-46; quiz 147. PubMed ID: 15024486
    [No Abstract]   [Full Text] [Related]  

  • 7. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium.
    Suleiman MS; Najib N; el-Sayed Y; Hasan M; Abdulahameed M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):276-9. PubMed ID: 2737796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetics of the new Russian prolonged-action form of diclofenac sodium--Ortopek--in a single oral dose].
    Kurapov AP; Starodubtsev AK; Rubtsova TM; Ignat'ev VG; Kemenova VA
    Eksp Klin Farmakol; 1995; 58(1):53-4. PubMed ID: 7787700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects.
    Raz I; Hussein Z; Samara E; Ben-David J
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):246-8. PubMed ID: 3410601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-way cross-over bioequivalence study comparing two products of diclofenac sodium suppositories in healthy human volunteers.
    Hasan M; Otoom S; Najib N; Sallam el-S
    Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):263-5. PubMed ID: 15569270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy of and tolerance to ketoprofen and diclofenac sodium in the treatment of rheumatoid arthritis.
    Boey ML; Rae S; Feng PH
    Singapore Med J; 1988 Jun; 29(3):240-5. PubMed ID: 3187575
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
    Ramakrishna S; Fadnavis NW; Diwan PV
    Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of rectal diclofenac and its hydroxy metabolites in man.
    Landsdorp D; Vree TB; Janssen TJ; Guelen PJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):298-302. PubMed ID: 2387653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open questions on bioequivalence: the case of multiple peak phenomenon.
    Marzo A; Reiner V
    J Pharm Pharmacol; 2004 Feb; 56(2):281-2. PubMed ID: 15005889
    [No Abstract]   [Full Text] [Related]  

  • 16. Diclofenac.
    Med Lett Drugs Ther; 1988 Dec; 30(780):109-11. PubMed ID: 3054450
    [No Abstract]   [Full Text] [Related]  

  • 17. No effect of short term ranitidine intake on diclofenac pharmacokinetics.
    Leucuţa A; Vlase L; Farcau D; Nanulescu M
    Rom J Gastroenterol; 2004 Dec; 13(4):306-8. PubMed ID: 15624028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
    Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
    Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.
    Rajaram L; Roy SK; Skerjanec A
    Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of a new sustained-release form of diclofenac sodium in humans.
    Mascher H
    Drug Des Deliv; 1989 Jun; 4(4):303-11. PubMed ID: 2775450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.